Adults With Congenital Heart Disease and Previous Intervention

Current Problems in Cardiology

Volumn 38, Issue 8, 2013, Pages 293-357

  Phillips, Sabrina D ^a   Bonnichsen, Crystal R ^a   McLeod, Christopher J ^a   Ammash, Naser M ^a   Burkhart, Harold M ^a   Connolly, Heidi M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HEPARIN; OCTREOTIDE; SILDENAFIL; TADALAFIL; WARFARIN;

ADULT; AORTA ANEURYSM; AORTA COARCTATION; AORTA DISEASE; AORTA ENLARGEMENT; AORTA VALVE REGURGITATION; ARTERIAL SWITCH OPERATION; ARTICLE; ATRIAL SWITCH PRODEDURE; ATRIOVENTRICULAR VALVE FAILURE; BICUSPID AORTIC VALVE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERY; DIAGNOSTIC ACCURACY; DIETARY INTAKE; DISEASE ASSOCIATION; EBSTEIN ANOMALY; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; FOLLOW UP; FONTAN PROCEDURE; FORWARD HEART FAILURE; GENETIC SCREENING; GREAT VESSELS TRANSPOSITION; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART DEATH; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE DUPLICATION; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEART VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTENSION; IATROGENIC DISEASE; IMPLANTED HEART PACEMAKER; INTRACARDIAC THROMBOSIS; INTRACRANIAL ANEURYSM; LEFT SIDE HEART OBSTRUCTION; LEFT SIDED HEART FAILURE; LIVER CIRRHOSIS; LUNG VEIN DRAINAGE ANOMALY; MEDICAL HISTORY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREGNANCY; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY CONDUIT FAILURE; PULMONARY HYPERTENSION; PULMONARY VALVE INSUFFICIENCY; PULMONARY VEIN OBSTRUCTION; RASTELLI OPERATION; RECURRENT DISEASE; REENTRY TACHYCARDIA; RESIDUAL SHUNT; RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION; RIGHT VENTRICULAR DYSFUNCTION; RIGHT VENTRICULAR SYSTOLIC DYSFUNCTION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SINUS NODE DISEASE; SPORT; STERNOTOMY; SURGICAL APPROACH; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; TRICUSPID VALVE PROSTHESIS; TRICUSPID VALVE REGURGITATION;

ADULT; CONTINUITY OF PATIENT CARE; ELECTROPHYSIOLOGICAL PROCESSES; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880942210     PISSN: 01462806     EISSN: 15356280     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2013.05.002     Document Type: Article

References (125)

1. Davia J.E., Cheitlin M.D., Bedynek J.L. Sinus venosus atrial septal defect: analysis of fifty cases. Am Heart J 1973, 85:177-185.
2. Freedom R.M., Culham J., Rowe R. Left atrial to coronary sinus fenestration (partially unroofed coronary sinus). Morphological and angiocardiographic observations. Br Heart J 1981, 46:63.
3. Ammash N.M., Seward J.B., Warnes C.A., Connolly H.M., O'Leary P.W., Danielson G.K. Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J Am Coll Cardiol 1997, 29:1351-1358.
4. Vesely T.M., Julsrud P.R., Brown J.J., Hagler D.J. MR imaging of partial anomalous pulmonary venous connections. J Comput Assist Tomogr 1991, 15:752-756.
5. Schatz S.L., Ryvicker M.J., Deutsch A.M., Cohen H.R. Partial anomalous pulmonary venous drainage of the right lower lobe shown by ct scans. Radiology 1986, 159:21-22.
6. Majdalany D.S., Phillips S.D., Dearani J.A., Connolly H.M., Warnes C.A. Isolated partial anomalous pulmonary venous connections in adults: twenty-year experience. Congenit Heart Dis 2010, 5:537-545.
7. Murphy J.G., Gersh B.J., McGoon M.D., et al. Long-term outcome after surgical repair of isolated atrial septal defect. N Engl J Med 1990, 323:1645-1650.
8. Cetta F.A., Ammash N. Anomalies of the pulmonary and systemic venous connections. Echocardiography in Pediatric and Adult Congenital Heart Disease 2010, 70-86. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. B.W. Eidem, F. Cetta, P.W. O'Leary (Eds.).
9. Divekar A., Gaamangwe T., Shaikh N., Raabe M., Ducas J. Cardiac perforation after device closure of atrial septal defects with the amplatzer septal occluder. J Am Coll Cardiol 2005, 45:1213-1218.
10. Drenthen W., Pieper P.G., Roos-Hesselink J.W., et al. Outcome of pregnancy in women with congenital heart disease a literature review. J Am Coll Cardiol 2007, 49:2303-2311.
11. Ammash N.M., Connolly H.M., Julsrud P.R., Seward J.B., Danielson G.K. Transesophageal echocardiography: unusual case of anomalous pulmonary venous connection to the azygos vein. J Am Soc Echocardiogr 1997, 10:738-744.
12. Li W., Somerville J. Atrial flutter in grown-up congenital heart (guch) patients. Clinical characteristics of affected population. Int J Cardiol 2000, 75:129-137. [discussion 138-129].
13. Gatzoulis M.A., Freeman M.A., Siu S.C., Webb G.D., Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999, 340:839-846.
14. Silversides C.K., Siu S.C., McLaughlin P.R., et al. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart 2004, 90:1194-1198.
15. Ghai A., Harris L., Harrison D.A., Webb G.D., Siu S.C. Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. J Am Coll Cardiol 2001, 37:585-592.
16. Bouchardy J., Therrien J., Pilote L., et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 2009, 120:1679-1686.
17. Magnin-Poull I., De Chillou C., Miljoen H., Andronache M., Aliot E. Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects. J Cardiovasc Electrophysiol 2005, 16:681-687.
18. Crandall M.A., Daoud E.G., Daniels C.J., Kalbfleisch S.J. Percutaneous radiofrequency catheter ablation for atrial fibrillation prior to atrial septal defect closure. J Cardiovasc Electrophysiol 2012, 23:102-104.
19. Miyazaki A., Ohuchi H., Kurosaki K.-i., Kamakura S., Yagihara T., Yamada O. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J 2008, 72:1998-2003.
20. Wells R., Khairy P., Harris L., Anderson C.C., Balaji S. Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin Electrophysiol 2009, 32:1313-1318.
21. Garson A., Gillette P.C., McVey P., et al. Amiodarone treatment of critical arrhythmias in children and young adults. J Am Coll Cardiol 1984, 4:749-755.
22. Teh A.W., Medi C., Lee G., et al. Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. Pacing Clin Electrophysiol 2011, 34:431-435.
23. Said S.M., Burkhart H.M., Schaff H.V., et al. Single-patch, 2-Patch, and caval division techniques for repair of partial anomalous pulmonary venous connections: does it matter?. J Thorac Cardiovasc Surg 2012, 143:896-903.
24. Stewart R.D., Bailliard F., Kelle A.M., Backer C.L., Young L., Mavroudis C. Evolving surgical strategy for sinus venosus atrial septal defect: effect on sinus node function and late venous obstruction. Ann Thorac Surg 2007, 84:1651-1655. [discussion 1655].
25. Campbell M. Natural history of coarctation of the aorta. Br Heart J 1970, 32:633-640.
26. Cohen M., Fuster V., Steele P.M., Driscoll D., McGoon D.C. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation 1989, 80:840-845.
27. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart diseases report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease) developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e143-e263.
28. Vriend J.W.J., Drenthen W., Pieper P.G., et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 2005, 26:2173-2178.
29. Beauchesne L.M., Connolly H.M., Ammash N.M., Warnes C.A. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 2001, 38:1728-1733.
30. Bonow R., Carabello B., Chatterjee K., et al. Writing committee members; American College of Cardiology/American Heart Association task force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:e523-e661.
31. Hiratzka L.F., Bakris G.L., Beckman J.A., et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010, 121:1544-1579.
32. Connolly H.M., Houston J., Brown R.D., Warnes C.A., Ammash N.M., Tajik A.J. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clin Proc 2003, 78:1491-1499.
33. Matura L.A., Ho V.B., Rosing D.R., Bondy C.A. Aortic dilatation and dissection in Turner syndrome. Circulation 2007, 116:1663-1670.
34. Oechslin E.N., Harrison D.A., Connelly M.S., Webb G.D., Siu S.C. Mode of death in adults with congenital heart disease. Am J Cardiol 2000, 86:1111-1116.
35. Pillutla P., Shetty K.D., Foster E. Mortality associated with adult congenital heart disease: trends in the us population from 1979 to 2005. Am Heart J 2009, 158:874-879.
36. Silka M.J., Hardy B.G., Menashe V.D., Morris C.D. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998, 32:245-251.
37. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg 2011, 142:1303-1338.
38. Klein R.C. Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. Am J Cardiol 1984, 53:1079-1083.
39. Olshausen K.V., Schwarz F., Apfelbach J., Röhrig N., Krämer B., Kübler W. Determinants of the incidence and severity of ventricular arrhythmias in aortic valve disease. Am J Cardiol 1983, 51:1103-1109.
40. Santinga J.T., Kirsh M.M., Brady T.J., Thrall J., Pitt B. Left ventricular function in patients with ventricular arrhythmias and aortic valve disease. Ann Thorac Surg 1983, 35:152-155.
41. Jost C.H.A., Schaff H.V., Connolly H.M., et al. Spectrum of reoperations after repair of aortic coarctation: importance of an individualized approach because of coexistent cardiovascular disease. Mayo Clin Proc 2002, 77:646-653.
42. Brown M.L., Burkhart H.M., Connolly H.M., Dearani J.A., Hagler D.J., Schaff H.V. Late outcomes of reintervention on the descending aorta after repair of aortic coarctation. Circulation 2010, 122:S81-S84.
43. McKellar S.H., Schaff H.V., Dearani J.A., et al. Intermediate-term results of ascending-descending posterior pericardial bypass of complex aortic coarctation. J Thorac Cardiovasc Surg 2007, 133:1504-1509.
44. Liebman J., Cullum L., Belloc N.B. Natural history of transposition of the great arteries: anatomy and birth and death characteristics. Circulation 1969, 40:237-262.
45. Blalock A., Hanlon C. The surgical treatment of complete transposition of the aorta and the pulmonary artery. Surg Gynecol Obstet 1950, 90:1.
46. Rashkind W.J., Miller W.W. Creation of an atrial septal defect without thoracotomy: a palliative approach to complete transposition of the great arteries. J Am Med Assoc 1966, 196:991-992.
47. Senning A. Surgical correction of transposition of the great vessels. Surgery 1959, 45:966.
48. Mustard W. Successful two-stage correction of transposition of the great vessels. Surgery 1964, 55:469.
49. Jatene A.D., Fontes V.F., Paulista P.P., et al. Anatomic correction of transposition of the great vessels. J Thorac Cardiovasc Surg 1976, 72:364-370.
50. Rastelli G.C., McGoon D.C., Wallace R.B. Anatomic correction of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis. J Thorac Cardiovasc Surg 1969, 58:545-552.
51. Clarkson P.M., Wilson N.J., Neutze J.M., North R.A., Calder A.L., Barratt-Boyes B.G. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994, 24:190-193.
52. Guédès A., Mercier L.-A., Leduc L., Bérubé L., Marcotte F., Dore A. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 2004, 44:433-437.
53. Roos-Hesselink J.W., Meijboom F.J., Spitaels S.E.C., et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J 2004, 25:1264-1270.
54. Moons P., Gewillig M., Sluysmans T., et al. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart 2004, 90:307-313.
55. Schultz A.H., Wernovsky G. Late outcomes in patients with surgically treated congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2005, 8:145-156.
56. Dearani J.A., Danielson G.K., Puga F.J., Mair D.D., Schleck C.D. Late results of the Rastelli operation for transposition of the great arteries. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2001, 4:3-15.
57. Kreutzer C., De Vive J., Oppido G., et al. Twenty-five-year experience with Rastelli repair for transposition of the great arteries. J Thorac Cardiovasc Surg 2000, 120:211-223.
58. Gelatt M., Hamilton R.M., McCrindle B.W., et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997, 29:194-201.
59. Dos L., Teruel L., Ferreira I.J., et al. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 2005, 91:652-656.
60. Hayes C.J., Gersony W.M. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J Am Coll Cardiol 1986, 7:133-137.
61. Kammeraad J.A.E., van Deurzen C.H.M., Sreeram N., et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 2004, 44:1095-1102.
62. Oechslin E., Jenni R. 40 Years after the first atrial switch procedure in patients with transposition of the great arteries: long-term results in Toronto and Zurich. Thorac Cardiovasc Surg 2000, 48:233-237.
63. Khairy P., Landzberg M.J., Gatzoulis M.A., et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation 2006, 113:2391-2397.
64. Sareyyupoglu B., Burkhart H.M., Hagler D.J., et al. Hybrid approach to repair of pulmonary venous baffle obstruction after atrial switch operation. Ann Thorac Surg 2009, 88:1710-1711.
65. Mavroudis C., Backer C.L. Arterial switch after failed atrial baffle procedures for transposition of the great arteries. Ann Thorac Surg 2000, 69:851-857.
66. Poirier N.C., Yu J.H., Brizard C.P., Mee R.B. Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch procedures. J Thorac Cardiovasc Surg 2004, 127:975-981.
67. Allwork S.P., Bentall H.H., Becker A.E., et al. Congenitally corrected transposition of the great arteries: morphologic study of 32 cases. Am J Cardiol 1976, 38:910-923.
68. Connolly H.M., Grogan M., Warnes C.A. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 1999, 33:1692-1695.
69. Piacentini G., Digilio M.C., Capolino R., et al. Familial recurrence of heart defects in subjects with congenitally corrected transposition of the great arteries. Am J Med Genet A 2005, 137A:176-180.
70. Warnes C.A. Transposition of the great arteries. Circulation 2006, 114:2699-2709.
71. Mongeon F.-P., Connolly H.M., Dearani J.A., Li Z., Warnes C.A. Congenitally corrected transposition of the great arteriesventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J Am Coll Cardiol 2011, 57:2008-2017.
72. Khairy P., Fournier A., Thibault B., Dubuc M., Thérien J., Vobecky S.J. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol 2006, 109:160-168.
73. Voskuil M., Hazekamp M.G., Kroft L.J.M., et al. Postsurgical course of patients with congenitally corrected transposition of the great arteries. Am J Cardiol 1999, 83:558-562.
74. Hauser M., Bengel F.M., Hager A., et al. Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients with congenitally corrected transposition of the great arteries. Heart 2003, 89:1231-1235.
75. Huhta J.C., Maloney J.D., Ritter D.G., Ilstrup D.M., Feldt R.H. Complete atrioventricular block in patients with atrioventricular discordance. Circulation 1983, 67:1374-1377.
76. Marcelletti C., Maloney J.D., Ritter D.G., Danielson G.K., McGoon D.C., Wallace R.B. Corrected transposition and ventricular septal defect: surgical experience. Ann Surg 1980, 191:751.
77. Giuliani E.R., Fuster V., Brandenburg R.O., Mair D.D. Ebstein's anomaly: the clinical features and natural history of Ebstein's anomaly of the tricuspid valve. Mayo Clin Proc 1979, 54:163-173.
78. Watson H. Natural history of Ebstein's anomaly of tricuspid valve in childhood and adolescence. An international co-operative study of 505 cases. Br Heart J 1974, 36:11.
79. Jost C.H.A., Connolly H.M., O'Leary P.W., Warnes C.A., Tajik A.J., Seward J.B. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc 2005, 80:361-368.
80. Quinonez L.G., Dearani J.A., Puga F.J., et al. Results of the 1.5-ventricle repair for Ebstein anomaly and the failing right ventricle. J Thorac Cardiovasc Surg 2007, 133:1303-1310.
81. Chauvaud S., Fuzellier J.F., Berrebi A., et al. Bi-directional cavopulmonary shunt associated with ventriculo and valvuloplasty in Ebstein's anomaly: benefits in high risk patients. Eur J Cardiothorac Surg 1998, 13:514-519.
82. Connolly H.M., Warnes C.A. Ebstein's anomaly: outcome of pregnancy. J Am Coll Cardiol 1994, 23:1194-1198.
83. Siu S.C., Sermer M., Colman J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001, 104:515-521.
84. Brown M.L., Dearani J.A., Danielson G.K., et al. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg 2008, 135(1120-1136):e1127.
85. Roten L., Lukac P., De Groot N., et al. Catheter ablation of arrhythmias in Ebstein's anomaly: a multicenter study. J Cardiovasc Electrophysiol 2011, 22:1391-1396.
86. Brown M.L., Dearani J.A., Danielson G.K., et al. Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol 2009, 103:555-561.
87. Dearani J.A., Said S.M., O'Leary P.W., Burkhart H.M., Barnes R.D., Cetta F. Anatomic repair of Ebstein's malformation: lessons learned with cone reconstruction. Ann Thorac Surg 2013, 95:220-228.
88. Canobbio M.M., Mair D.D., van der Velde M., Koos B.J. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996, 28:763-767.
89. Thacker D., Patel A., Dodds K., Goldberg D.J., Semeao E., Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2010, 89:837-842.
90. John A.S., Driscoll D.J., Warnes C.A., Phillips S.D., Cetta F. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2011, 92:1451-1456.
91. Kelly A.M., Feldt R.H., Driscoll D.J., Danielson G.K. Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease. Mayo Clin Proc 1998, 73:777-779.
92. Vyas H., Driscoll D.J., Cabalka A.K., Cetta F., Hagler D.J. Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv 2007, 69:584-589.
93. Uzun O., Wong J.K., Bhole V., Stumper O. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg 2006, 82:e39-e40.
94. Landzberg B., Pochapin M. Protein-losing enteropathy and gastropathy. Curr Treat Options Gastroenterol 2001, 4:39-49.
95. Kiesewetter C.H., Sheron N., Vettukattill J.J., et al. Hepatic changes in the failing Fontan circulation. Heart 2007, 93:579-584.
96. Gelatt M., Hamilton R.M., McCrindle B.W., et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994, 24:1735-1741.
97. Mavroudis C., Deal B.J., Backer C.L., Tsao S. Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg 2008, 86:857.
98. Mavroudis C., Backer C.L., Deal B.J. Late reoperations for Fontan patients: state of the art invited review. Eur J Cardiothorac Surg 2008, 34:1034-1040.
99. Takahashi K., Fynn-Thompson F., Cecchin F., Khairy P., del Nido P., Triedman J.K. Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Int J Cardiol 2009, 137:260-266.
100. Sharma V., Burkhart H.M., Cetta F., Hagler D.J., Phillips S.D., Dearani J.A. Fontan conversion to one and one half ventricle repair. Ann Thorac Surg 2012, 94:1269-1274.
101. Murphy J.G., Gersh B.J., Mair D.D., et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993, 329:593-599.
102. Veldtman G.R., Connolly H.M., Grogan M., Ammash N.M., Warnes C.A. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004, 44:174-180.
103. Beauchesne L.M., Warnes C.A., Connolly H.M., et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 2005, 45:595-598.
104. Ammash N.M., Dearani J.A., Burkhart H.M., Connolly H.M. Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis 2007, 2:386-403.
105. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
106. Khairy P., Aboulhosn J., Gurvitz M.Z., et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010, 122:868-875.
107. Babu-Narayan S.V., Kilner P.J., Li W., et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 2006, 113:405-413.
108. Niwa K. Aortic root dilatation in tetralogy of Fallot long-term after repair-histology of the aorta in tetralogy of Fallot: evidence of intrinsic aortopathy. Int J Cardiol 2005, 103:117-119.
109. Nollert G., Fischlein T., Bouterwek S., Böhmer C., Klinner W., Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997, 30:1374-1383.
110. McLeod C.J., Kapa S., Asirvatham S.J. Implantable cardioverter-defibrillator therapy in congenital heart disease. Expert Rev Med Devices 2010, 7:1-3.
111. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51:e1-e62.
112. Harrison D.A., Siu S.C., Hussain F., MacLoghlin C.J., Webb G.D., Harris L. Sustained atrial arrhythmias in adults late after repair of tetralogy of Fallot. Am J Cardiol 2001, 87:584-588.
113. Oosterhof T., van Straten A., Vliegen H.W., et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007, 116:545-551.
114. Lee C., Kim Y.M., Lee C.-H., et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012, 60:1005-1014.
115. Dearani J.A., Burkhart H.M., Stulak J.M., Sundt T.M., Schaff H.V. Management of the aortic root in adult patients with conotruncal anomalies. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009, 12:122-129.
116. Stulak J.M., Dearani J.A., Burkhart H.M., Sundt T.M., Connolly H.M., Schaff H.V. Does the dilated ascending aorta in an adult with congenital heart disease require intervention?. J Thorac Cardiovasc Surg 2010, 140:S52-S57.
117. Baumgartner H., Bonhoeffer P., De Groot N.M.S., et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010): the task force on the management of grown-up congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2915-2957.
118. Butera G., Carminati M., Chessa M., et al. Transcatheter closure of perimembranous ventricular septal defects early and long-term results. J Am Coll Cardiol 2007, 50:1189-1195.
119. Mongeon F.-P., Burkhart H.M., Ammash N.M., et al. Indications and outcomes of surgical closure of ventricular septal defect in adults. JACC Cardiovasc Interv 2010, 3:290-297.
120. Galiè N., Beghetti M., Gatzoulis M.A., et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006, 114:48-54.
121. Ohkita Y., Miki S., Kusuhara K., et al. Reoperation after aortic valvuloplasty for aortic regurgitation associated with ventricular septal defect. Ann Thorac Surg 1986, 41:489-491.
122. Kidd L., Driscoll D.J., Gersony W.M., et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 1993, 87:I38-I51.
123. Cohle S.D., Balraj E., Bell M. Sudden death due to ventricular septal defect. Pediatr Dev Pathol 1999, 2:327-332.
124. Liberman L., Kaufman S., Alfayyadh M., Hordof A.J., Apfel H.D. Noninvasive prediction of pulmonary artery pressure in patients with isolated ventricular septal defect. Pediatr Cardiol 2000, 21:197-201.
125. Moller J.H., Patton C., Varco R.L., Lillehei C.W. Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. Am J Cardiol 1991, 68:1491-1497.